Alzheimer sjúkan er ein progressiv neurologisk sjúka, sum ger, at heilakyknur vikna og doyggja, og tað førir til minking í minni, hugsun og hugsanarevni.
Tað er tann mest vanliga orsøkin til demens, og svarar til 60-80% av øllum tilburðum.
Sjúkan er endaliga deyðilig, og miðal livialdurin eftir diagnosu er 4-8 ár, tó at summi fólk kunnu liva upp til 20 ár við sjúkuni.
Deyðstíttleikin fyri Alzheimers sjúku er ymiskur alt eftir kanningini og hvørjum bólki, ið verður kannaður.
Sambært Alzheimerfelagnum er Alzheimer smittuni tann sætta høvuðsorsøkin til deyða í USA, og hon er tann fimta høvuðsorsøkin til deyða hjá teimum, sum eru 65 ár og eldri.
Í 2019 varð Alzheimer sjúka melda sum tann undirliggjandi deyðsorsøkin hjá 121.9444 fólkum í USA.
Tað er týdningarmikið at leggja til merkis, at deyðstíttleikin av Alzheimer sjúku ikki bert er orsakað av sjálvari sjúku, men eisini av komplikatiónum og øðrum heilsuligum trupulleikum, sum standast av sjúkuni.
Tá sjúkan versnar, kann tað vera trupult at gera gerandisligar gerðir, so sum at eta, vaska sær og lata seg í, og hetta kann elva til føðslutrot, smittu og aðrar heilsutrupulleikar.
Fólk við Alzheimer kunnu eisini vera í størri vanda fyri at detta, fáa lungnabruna og aðrar smittuvandar.
Hóast tað í løtuni ikki finst nøkur viðgerð fyri Alzheimers sjúku, eru viðgerðir til taks, sum kunnu hjálpa við at handfara sjúkueyðkennini og betra um lívsgóðskuna.
Gransking fer fram fyri at menna nýggjar viðgerðir og at finna eina endaliga loysn á hesi ræðuligu sjúku.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
['Avsakan: sjúkuviðurskifti']
['Henda heimasíðan er bert til undirvísingar og kunningar og er ikki ætlað sum læknalig ráðgeving ella faklig tænasta.']
['Upplýsingarnar eiga ikki at verða nýttar til at staðfesta ella viðgera nakran heilsutrupulleika ella sjúku, og tey, sum ynskja persónliga læknahjálp, eiga at venda sær til ein autoriseraðan lækna.']
['Gev gætur, at tað neuronala netið, sum gevur svar uppá spurningarnar, er serliga skeivt, tá ið talan er um talgilda innihaldið, t.d. talið av fólki, sum hava fingið staðfest eina ávísa sjúku.']
['Spyr altíð læknan ella annan skikkaðan heilsuhjálpara um ráðgeving í sambandi við sjúku. Vanvirð ongantíð professionella læknaráðgeving ella drála við at leita eftir henni vegna okkurt, tú hevur lisið á hesi heimasíðu.']
['Avsakan: upphavsrættur']
['Digital Millennium Copyright Act frá 1998, 17 U.S.C. § 512 (DMCA) gevur rætt til at kæra til rættindahavarar, sum halda, at tilfar, sum kemur á internetið, brýtur teirra rættindi sambært amerikanskum lógum um upphavsrætt. ']
['Um tú í góðari trúgv heldur, at eitthvørt innihald ella tilfar, sum er gjørt tøkt í sambandi við okkara heimasíðu ella tænastur, brýtur tíni upphavsrættindi, kanst tú (ella tín umboðsmaður) senda okkum eina fráboðan, har tú biður um, at innihaldið ella tilfarið verður tikið burtur ella atgongdin til tað verður sperrað.']
['Tilmeldingarnar skulu verða skrivligar við telduposti (sí "Kontakt" fyri teldupostadressu).']
['DMCA krevur, at fráboðan um meint brot á upphavsrættin skal innihalda hesar upplýsingar: (1) lýsing av tí upphavsrættarliga verkinum, sum talan er um, (2) lýsing av tí meinta brot á upphavsrættin og upplýsingar, sum eru nøktandi til at vit kunnu finna innihaldið (3) upplýsingar um teg, t.d. tín bústað, telefonnummar og teldupostbústað (4) eina váttan frá tær um, at tú í góðari trúgv heldur, at innihaldið, sum tú klagar um, ikki er loyvt av rættindahavanum ella umboði hansara ella sambært lóggávu']
['5) eina váttan frá tær, undirskrivað undir revsing fyri lygi, um, at upplýsingarnar í fráboðanini eru rættar, og at tú hevur heimild at gera galdandi upphavsrættin, sum verður hildin at vera brotin,']
['og 6) fysiska ella elektroniska undirskrift hjá rættindahavara ella persóni, sum hevur loyvi at virka fyri rættindahavara.']
['Um tú ikki hevur upplýst allar omanfyri nevndu upplýsingar, kann tað hava við sær, at viðgerðin av klaguni verður seinkað.']
['Set teg í samband við']
['Vinarliga send okkum ein teldupost við einum hvørjum spurningi/uppskoti.']
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Umleið']
['BioMedLib nýtir sjálvvirkandi teldur (maskinlæringaralgoritmur) til at gera spurningar og svar.']
['Vit byrja við 35 milliónum av biomedicinskum útgávum frá PubMed/Medline. eisini heimasíðum frá RefinedWeb.']
